TGF‐β signaling is dynamically regulated during the alveolarization of rodent and human lungs
Miguel A. Alejandre Alcázar(University of Cologne), Rory E. Morty(Heidelberg University), Werner Seeger(Justus-Liebig-Universität Gießen), Alfin G. Vicencio(Icahn School of Medicine at Mount Sinai), Gabriel G. Haddad(University of California San Diego), Dick Tibboel(Erasmus University Rotterdam), Irwin Reiss(Erasmus MC - Sophia Children’s Hospital), Ronald R. de Krijger(University Medical Center Utrecht), Julie Ryu(University of California San Diego), Matthias Michiels-Corsten(Justus-Liebig-Universität Gießen), Oliver Eickelberg(Ludwig-Maximilians-Universität München)
Cited by 98
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
|The Lancet|2002|771
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683